Health ❯Pharmaceuticals

Drug Safety

FDA Regulations Carcinogens FDA Approval Recalls Health Risks Cancer Risk Cancer Risks Adverse Effects Adverse Drug Reactions Manufacturing Inspections Chirality in Drugs Sodium Valproate Litigation Hormonal Therapies Legal Issues Regulatory Affairs Drug Recalls Weight Loss Drugs Medication Review Advertising Practices Contaminated Products Opioids Mifepristone Overdose Risks Abortifacient Drugs Market Withdrawals Adulterated Products Market Withdrawal Environmental Health Side Effects Counterfeit Medicines Drug Importation Organ Damage Zantac Counterfeit Drugs GLP-1 Drugs Product Recalls Contaminants Pharmacovigilance Medication Side Effects

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

Pfizer Ends Development of Danuglipron Over Safety Concerns

Nitisinone Identified as Promising Mosquito-Killing Tool in Malaria Fight

Pharma Experts Warn of Deadly TikTok 'Paracetamol Challenge'

Texas Lawsuit Against New York Doctor Tests Legal Boundaries of Abortion Pill Access

FDA Recalls Over 233,000 Bottles of Antidepressant Duloxetine for Cancer-Causing Impurity

FDA Moves to Ban Ineffective Oral Phenylephrine from Cold Medicines

FDA Enforces New Clarity Rules for TV Drug Advertisements

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Warning Issued Over Dangerous Erectile Dysfunction Drug

FDA Recalls Duloxetine Over Cancer-Causing Chemical Concerns

GSK Agrees to $2.2 Billion Settlement Over Zantac Cancer Claims

21 Republican AGs Challenge Pediatricians on Puberty Blockers

FDA Faces Backlog of 2,000 Uninspected Drug Plants Post-COVID

Lawsuit Highlights Severe Side Effects of Popular Weight-Loss Drugs

Criminal Networks Exploit Fake Ozempic Batch Numbers to Circulate Dangerous Drugs

New Study Links Ozempic to Increased Risk of Suicidal Thoughts

New Study Fuels Debate on Semaglutide's Mental Health Risks

GSK Faces Major Legal Setback as 70,000 Zantac Lawsuits Proceed